Spotlight on NPs highlights exciting achievements and activities of American Association of Nurse Practitioners (AANP) members.
Congratulations to AANP Fellow Dr. Teri Moser Woo, who is the new director of the RN-to-BSN nursing program at Saint Martin’s University. “Dr. Woo brings in a wealth of experience in program development and management, strong relationships in the nursing education community, and a passion for the role of nursing education at a Catholic university. I am very excited about her joining us and look forward to the growth of this program in the near future,” said Jeff Crane, Ph.D., dean of the College of the Arts and Sciences. Read the press release.
For Patient Safety Awareness Week, AANP member Dr. Nicholas Carte co-authored an article on patient safety that was published by Southern New Hampshire University. The article lists communication and culture as primary factors and encourages clinicians to promote an ongoing dialogue with patients. Polypharmacy as a safety concern for older patients was also discussed.
A Home Health Care News article about developing a business case for palliative and community-based care quoted AANP member Rachel Cardoza. The article described steps one health system took to increase patients’ access to care and indicated that “Proving the business case for offering palliative care in addition to other services could help provide a pathway for wider access and funding in the future.”
AANP member Elisabeth Volpert is “determined to increase primary care access and improve health outcomes,” according to an article by the University of Louisville. “Over the past 10 years, I’ve seen patients turned away because of a lack of primary care providers,” Volpert said. “There is a great opportunity for advanced practice nurses – who are highly educated and equipped to provide evidence-based primary care – to fill that gap.”
A new at-home DNA breast cancer test may not provide patients a complete analysis of their risk, according to an article that quoted AANP member Elisabeth King. “About half the patients we follow for high-risk actually have negative genetic testing,” King said, “but they still have this concerning family history that we can’t explain. We’re still worried about you even though we haven’t found the thing causing all of the cancer in your family.”